Welcome
Support Centre
21 September 2014 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   news
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes
statistics

[ Print-friendly version ]
DESMOND (Diabetes Education and Self Management for Ongoing and Newly Diagnosed): a randomised controlled trial of a structured group education programme for people newly diagnosed with type two diabetes
ISRCTN ISRCTN17844016
DOI 10.1186/ISRCTN17844016
ClinicalTrials.gov identifier
EudraCT number
Public title DESMOND (Diabetes Education and Self Management for Ongoing and Newly Diagnosed): a randomised controlled trial of a structured group education programme for people newly diagnosed with type two diabetes
Scientific title
Acronym DESMOND
Serial number at source N/A
Study hypothesis To evaluate the effectiveness and feasibility of delivering structured group self-management education to individuals newly diagnosed with type two diabetes.
Lay summary Not provided at time of registration
Ethics approval Approval received from Multi-centre Research Ethics Committee (MREC) on the 16th June 2004.
Study design Cluster randomised controlled trial
Countries of recruitment United Kingdom
Disease/condition/study domain Self management of type two diabetes
Participants - inclusion criteria 1. Greater than 18 years of age
2. Referred to the study within four weeks of diagnosis of type two diabetes
3. In intervention group, able to attend the intervention within 12 weeks of diagnosis
Participants - exclusion criteria 1. Are unable to give informed consent
2. Have been recruited to take part, or are already taking part in other research
3. Have severe and enduring mental health problems
4. Are not primarily responsible for their own care
5. Are unable to participate in a group programme
6. Have insufficient understanding of English to participate in the group education
Anticipated start date 01/07/2004
Anticipated end date 31/01/2007
Status of trial Completed
Patient information material
Target number of participants 1,000
Interventions A programme of six hours of structured group education consisting of two three-hour sessions offered as either one day or two half-days, facilitated by two health care professionals trained to deliver the intervention to groups of up to ten people newly diagnosed with type two diabetes, who may be accompanied by a partner, family member or friend.

This is compared to a control group receiving enhanced routine care.
Primary outcome measure(s) Glycaemic control as measured by HbA1c at 12 months.
Secondary outcome measure(s) 1. Cardiovascular (CV) risk as measured by lipid profile and blood pressure
2. Quality of life indicators, diabetes control, self-care and illness belief perceptions of patients at 12 months
Sources of funding 1. Diabetes UK (UK) (ref: BDA:RD04/0002922)
2. Department of Health (UK)
3. NovoNordisk (UK) - unrestricted educational grant
Trial website
Publications 1. 2008 results in http://www.ncbi.nlm.nih.gov/pubmed/18276664
2. 2012 results in http://www.ncbi.nlm.nih.gov/pubmed/22539172
Contact name Prof  Melanie  Davies
  Address Leicester Diabetes Centre (Broadleaf)
Leicester General Hospital
Gwendolen Road
  City/town Leicester
  Zip/Postcode LE5 4PW
  Country United Kingdom
Sponsor University Hospitals of Leicester NHS Trust (UK)
  Address Gwendolen House
Gwendolen Road
  City/town Leicester
  Zip/Postcode LE5 4PW
  Country United Kingdom
  Sponsor website: http://www.uhl-tr.nhs.uk/
Date applied 19/04/2007
Last edited 30/07/2012
Date ISRCTN assigned 16/05/2007
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2014 ISRCTN unless otherwise stated.